跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
利奈唑胺葡萄糖注射液 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Linezolid and Glucose Injection
Approved
化学药品
Linezolid and Glucose Injection
南光化學製藥股份有限公司
🇨🇳 National Medical Products Administration
Approval Date
Nov 5, 2024
Approval ID
8eX3bDt1ste
Company
南光化學製藥股份有限公司
Type
化学药品
Approval Details
Approval Id
8eX3bDt1ste
Approval Number
国药准字HC20240008
Generic Name
利奈唑胺葡萄糖注射液
Generic Name En
Linezolid and Glucose Injection
Drug Type
化学药品
Dosage Form
注射剂
Strength
300ml:利奈唑胺0.6g与葡萄糖15.0g
Reg Date
2024-11-05
Expired Date
2029-11-04
Company Name
南光化學製藥股份有限公司
Company Address
No. 1001, 1001-1, Zhongshan Rd., XinHua Dist., Tainan City, Taiwan, China
Production Company Name
nang kuang pharmaceutical co., ltd
Production Company Address
No. 1001, 1001-1, Zhongshan Rd., XinHua Dist., Tainan City, Taiwan, China
Company Detail Path
/organization/nan-guang-hua-xue-zhi-yao-gu-fen-you-xian-gong-si
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 5, 2024
Approval ID
8eX3bDt1ste
Type
化学药品
Back to NMPA Approvals